Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes
Retrospective Study #1 A retrospective analysis published in 2025 reviewed the medical charts of 283 adults who had been prescribed GLP1 receptor agonists and later visited a dermatology clinic for concerns about hair loss between 2021 and 2023
serves patients in and around: Hartford CT, East Hartford CT, South Windsor CT, Manchester CT, West Hartford CT, Farmington CT, Avon CT, Simsbury CT, Wethersfield CT, Bloomfield CT, Newington CT, Windsor CT, Rocky Hill CT, Bristol CT, East Glastonbury CT, South Glastonbury CT
Keep the vial tightly sealed
Food and Drug Administration (FDA) for: Semaglutide is approved by the FDA for: Lets dive into how each medication works